Microscience Ltd.
This article was originally published in Start Up
Executive Summary
Microscience's platform includes a mucosal vaccine delivery program and a functional genomics program called {Signature-Tagged Mutagenesis}. The company hopes to develop vaccines and anti-infective candidates.